Pharmaceutical Industry Aijaz Tobaccowalla New MD for Pfizer in India
Pfizer has appointed Aijaz Tobaccowalla as Managing Director, India. He will succeed Kewal Handa, who earlier this year announced his intention to retire in August 2012.
Mumbai/India – “With more than 20 years of experience in the pharmaceutical industry, Aijaz, “Jazz” is a seasoned leader who will continue to lead Pfizer India through this exciting period. His leadership experience, demonstrated versatility, and successful management in a constantly changing business environment, make him the ideal leader for Pfizer India”, said Ahmet Goksun, Regional President, Emerging Markets Europe, Russia, India and Turkey (EURIT), a part of the Emerging Markets Business Unit.
More than 20 Years in Pharma
Tobaccowalla joined Wyeth in 1991 and since then has held a number of positions in Business Technology as a member of the leadership teams of Pfizer WBB, R&D, and PCBU. In 2009 he was appointed to his most recent role, leading Business Technology for all biopharmaceutical business units.
Although there is a broad consensus that growth in the pharmaceutical industry will most likely come from the emerging markets, the opportunities for deals and acquisitions are limited. Acquisitions in these markets remain difficult for Big Pharma due to lack of suitable targets and government and regulatory constraints more in Opportunities for Pharmaceutical Companies in Emerging Markets Still Limited!
This article is protected by copyright. You want to use it for your own purpose? Contact us at support.vogel.de (ID: 34691840)